These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 10613780)
1. Pulmonary function, serum markers of inflammation, and IgG antibodies to core lipopolysaccharide of Burkholderia cepacia in adults with cystic fibrosis, following colonization with Burkholderia cepacia. Hendry J; Nixon L; Dodd M; Elborn JS; Govan J; Shale DJ; Webb AK Pediatr Pulmonol; 2000 Jan; 29(1):8-10. PubMed ID: 10613780 [TBL] [Abstract][Full Text] [Related]
2. Antibody response to Burkholderia cepacia in patients with cystic fibrosis colonized with Burkholderia cepacia and Pseudomonas aeruginosa. Hendry J; Butler S; Elborn JS; Govan JR; Nelson J; Shale DJ; Webb AK J Infect; 2000 Mar; 40(2):164-70. PubMed ID: 10841094 [TBL] [Abstract][Full Text] [Related]
3. Serum IgG and sputum IgA antibody to core lipopolysaccharide antigen from Pseudomonas cepacia in patients with cystic fibrosis. Nelson JW; Butler SL; Brown PH; Greening AP; Govan JR J Med Microbiol; 1993 Jul; 39(1):39-47. PubMed ID: 7686977 [TBL] [Abstract][Full Text] [Related]
4. Serum IgG response to Burkholderia cepacia outer membrane antigens in cystic fibrosis: assessment of cross-reactivity with Pseudomonas aeruginosa. Lacy DE; Smith AW; Stableforth DE; Smith G; Weller PH; Brown MR FEMS Immunol Med Microbiol; 1995 Feb; 10(3-4):253-61. PubMed ID: 7539670 [TBL] [Abstract][Full Text] [Related]
5. Cystic fibrosis: inflammatory response to infection with Burkholderia cepacia and Pseudomonas aeruginosa. Hendry J; Elborn JS; Nixon L; Shale DJ; Webb AK Eur Respir J; 1999 Aug; 14(2):435-8. PubMed ID: 10515426 [TBL] [Abstract][Full Text] [Related]
6. Outcome of Burkholderia cepacia colonisation in an adult cystic fibrosis centre. Ledson MJ; Gallagher MJ; Jackson M; Hart CA; Walshaw MJ Thorax; 2002 Feb; 57(2):142-5. PubMed ID: 11828044 [TBL] [Abstract][Full Text] [Related]
7. Immunolocalisation of Burkholderia cepacia in the lungs of cystic fibrosis patients. Sajjan U; Corey M; Humar A; Tullis E; Cutz E; Ackerley C; Forstner J J Med Microbiol; 2001 Jun; 50(6):535-546. PubMed ID: 11393291 [TBL] [Abstract][Full Text] [Related]
8. Burkholderia (Pseudomonas) cepacia epidemiology in a cystic fibrosis population: a genome finger-printing study. Cazzola G; Amalfitano G; Tonolli E; Perazzoli C; Piacentini I; Mastella G Acta Paediatr; 1996 May; 85(5):554-7. PubMed ID: 8827098 [TBL] [Abstract][Full Text] [Related]
9. Outcome of Burkholderia (Pseudomonas) cepacia colonisation in children with cystic fibrosis following a hospital outbreak. Whiteford ML; Wilkinson JD; McColl JH; Conlon FM; Michie JR; Evans TJ; Paton JY Thorax; 1995 Nov; 50(11):1194-8. PubMed ID: 8553277 [TBL] [Abstract][Full Text] [Related]
10. Burkholderia (Pseudomonas) cepacia and cystic fibrosis: the epidemiology in Belgium. Revets H; Vandamme P; Van Zeebroeck A; De Boeck K; Struelens MJ; Verhaegen J; Ursi JP; Verschraegen G; Franckx H; Malfroot A; Dab I; Lauwers S Acta Clin Belg; 1996; 51(4):222-30. PubMed ID: 8858887 [TBL] [Abstract][Full Text] [Related]
11. Predictors of mortality in adults with cystic fibrosis. Courtney JM; Bradley J; Mccaughan J; O'Connor TM; Shortt C; Bredin CP; Bradbury I; Elborn JS Pediatr Pulmonol; 2007 Jun; 42(6):525-32. PubMed ID: 17469153 [TBL] [Abstract][Full Text] [Related]
12. [Isolation frequency of Burkholderia cepacia from cystic fibrosis patients]. Ocak F; Gözalan A; Ozçelik U; Anadol D; Kiper N; Aktepe OC; Göçmen A; Esen B Mikrobiyol Bul; 2002 Jan; 36(1):1-10. PubMed ID: 12476760 [TBL] [Abstract][Full Text] [Related]
13. Effect of antibiotic treatment on inflammatory markers and lung function in cystic fibrosis patients with Pseudomonas cepacia. Peckham D; Crouch S; Humphreys H; Lobo B; Tse A; Knox AJ Thorax; 1994 Aug; 49(8):803-7. PubMed ID: 7522353 [TBL] [Abstract][Full Text] [Related]
14. Pseudomonas aeruginosa and Burkholderia cenocepacia infections in patients affected by cystic fibrosis: serum resistance and antibody response. Savoia D; Deplano C; Zucca M Immunol Invest; 2008; 37(1):19-27. PubMed ID: 18214797 [TBL] [Abstract][Full Text] [Related]
15. A comparison of pulmonary exacerbations with single and multiple organisms in patients with cystic fibrosis and chronic Burkholderia cepacia infection. Mc Manus TE; Moore JE; Crowe M; Dunbar K; Elborn JS J Infect; 2003 Jan; 46(1):56-9. PubMed ID: 12504610 [TBL] [Abstract][Full Text] [Related]
17. Pseudomonas aeruginosa and Burkholderia cepacia cannot be detected by PCR in the breath condensate of patients with cystic fibrosis. Vogelberg C; Hirsch T; Rösen-Wolff A; Kerkmann ML; Leupold W Pediatr Pulmonol; 2003 Oct; 36(4):348-52. PubMed ID: 12950050 [TBL] [Abstract][Full Text] [Related]
18. Burkholderia cepacia: medical, taxonomic and ecological issues. Govan JR; Hughes JE; Vandamme P J Med Microbiol; 1996 Dec; 45(6):395-407. PubMed ID: 8958242 [TBL] [Abstract][Full Text] [Related]
19. Host inflammatory responses to first isolation of Pseudomonas aeruginosa from sputum in cystic fibrosis. Elborn JS; Cordon SM; Shale DJ Pediatr Pulmonol; 1993 May; 15(5):287-91. PubMed ID: 8327287 [TBL] [Abstract][Full Text] [Related]
20. Distribution and transmission of Pseudomonas aeruginosa and Burkholderia cepacia in a hospital ward. Döring G; Jansen S; Noll H; Grupp H; Frank F; Botzenhart K; Magdorf K; Wahn U Pediatr Pulmonol; 1996 Feb; 21(2):90-100. PubMed ID: 8882212 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]